Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study

Yoshifumi Fukushima(Juntendo University), Takafumi Hiro(Nihon University), Masayoshi Takeuchi(Kanazawa Medical University), Takatoshi Kasai(Juntendo University), Yukio Ozaki(Kyushu University), Hiroyuki Daida(Juntendo University Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Takeshi Kimura(Municipal Hirakata City Hospital), Masakazu Yamagishi, Katsumi Miyauchi(Tokyo Metropolitan Geriatric Hospital), Masunori Matsuzaki(Ube (Japan)), Sho‐ichi Yamagishi(SHOWA Medical University)
Cardiovascular Diabetology
January 7, 2013
10.1186/1475-2840-12-5
Cited by 62

Related Papers

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A
|Journal of Biological Chemistry|2001|620
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582